Amendment Of 510(k) Exemption Petition Resets 180-Day Review Deadline
This article was originally published in The Gray Sheet
Amendment of a 510(k) exemption petition will reset the 180-day review hammer set by the FDA Modernization Act, the agency says in its recently released "Procedures for Class II Device Exemptions from Premarket Notification, Guidance for Industry and CDRH Staff."
You may also be interested in...
FDA approval of Abbott Laboratories' petition for 510(k) exemption for the firm's hypothyroidism total triiodothyronine (T3) test system would be the second for an Abbott T3 assay, albeit for a different indication.
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.